POMLOVYD Trademark

Trademark Overview

On Friday, November 2, 2012, a trademark application was filed for POMLOVYD with the United States Patent and Trademark Office. The USPTO has given the POMLOVYD trademark a serial number of 85770224. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 17, 2020. This trademark is owned by Celgene Corporation. The POMLOVYD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancers and blood diseases
pomlovyd

General Information

Serial Number85770224
Word MarkPOMLOVYD
Filing DateFriday, November 2, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 17, 2020
Registration Number4446412
Registration DateTuesday, December 10, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancers and blood diseases
Translation of Words in MarkThe wording "POMLOVYD" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, July 17, 2020CANCELLED SEC. 8 (6-YR)
Monday, December 10, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 10, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, September 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 19, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 9, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 8, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 8, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 6, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, July 19, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, July 19, 2013INQUIRY TO SUSPENSION E-MAILED
Friday, July 19, 2013SUSPENSION INQUIRY WRITTEN
Friday, January 18, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 18, 2013LETTER OF SUSPENSION E-MAILED
Friday, January 18, 2013SUSPENSION LETTER WRITTEN
Wednesday, January 16, 2013DATA MODIFICATION COMPLETED
Tuesday, January 15, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, January 15, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 15, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, January 15, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, January 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 11, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 10, 2013ASSIGNED TO LIE
Tuesday, January 8, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 7, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 7, 2013NON-FINAL ACTION E-MAILED
Monday, January 7, 2013NON-FINAL ACTION WRITTEN
Monday, January 7, 2013ASSIGNED TO EXAMINER
Thursday, November 8, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 6, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

pomlovyd pharmaceutical preparations certain treatment blood diseases system cancers modulate namely